{"id":13203,"date":"2022-12-15T14:07:25","date_gmt":"2022-12-15T14:07:25","guid":{"rendered":"https:\/\/apps.nhslothian.scot\/refhelp\/?page_id=13203"},"modified":"2025-12-04T17:12:07","modified_gmt":"2025-12-04T17:12:07","slug":"post-exposure-prophylaxis-for-chicken-pox-and-shingles-varicella-zoster","status":"publish","type":"page","link":"https:\/\/apps.nhslothian.scot\/refhelp\/guidelines\/infectiousdiseases\/post-exposure-prophylaxis-for-chicken-pox-and-shingles-varicella-zoster\/","title":{"rendered":"Post-exposure Prophylaxis for Chicken Pox and Shingles (Varicella Zoster)"},"content":{"rendered":"\n<p><strong>Please see full details at: <a href=\"https:\/\/www.gov.uk\/government\/publications\/post-exposure-prophylaxis-for-chickenpox-and-shingles\/guidelines-on-post-exposure-prophylaxis-pep-for-varicella-or-shingles-january-2023\" target=\"_blank\" rel=\"noreferrer noopener\">post-exposure prophylaxis guidance for varicella or shingles<\/a>.<\/strong><\/p>\n\n\n\n<p>Chickenpox (varicella) infection in immunosuppressed individuals, susceptible pregnant individuals and neonates can result in severe and even life-threatening varicella disease. Post-exposure prophylaxis (PEP) is recommended to attenuate disease and reduce the risk of complications such as pneumonitis, rather than to prevent infection in these at-risk individuals.<\/p>\n\n\n\n<p>Previously this was achieved through intramuscular varicella zoster immunoglobulin (VZIG), but this is no longer available, and antiviral prophylaxis is now recommended for all at risk groups including susceptible neonates. Exceptions include neonates whose mother develops chickenpox 7 days before to 7 days after delivery, when antivirals should be supplemented with intravenous (i.v.) varicella immunoglobulin. A bolus dose of IVIG may also be considered for eligible groups for whom oral antivirals are contraindicated.<\/p>\n\n\n\n<p><strong><em>For immunocompetent individuals including pregnant individuals, a history of previous chickenpox, shingles or 2 doses of varicella vaccine is sufficient evidence of immunity.<\/em><\/strong><\/p>\n\n\n\n<p><strong><mark style=\"background-color:#ffffff\" class=\"has-inline-color has-alert-red-color\">A pregnant or immunosuppressed patient with a VZV IgG negative result will need antiviral prophylaxis from day 7 after first exposure. Please note that anti-VZV IgG is not assessed at booking, but \u2013 where available \u2013 the retained booking sample can be used for subsequent testing on request.&nbsp; Clinicians should email the duty virologist <\/mark>(<\/strong><a href=\"mailto:loth.virologyadvice@nhs.scot\"><strong>loth.virologyadvice@nhs.scot<\/strong><\/a><strong>) <mark style=\"background-color:#ffffff\" class=\"has-inline-color has-alert-red-color\">with patient details to request this. Where there is no available booking sample, this information helps the laboratory team look out for the new clotted blood sample (brown tube).<\/mark><\/strong><\/p>\n\n\n\n<p><strong><mark style=\"background-color:#ffffff\" class=\"has-inline-color has-alert-red-color\">If urgent, please call the duty virologist instead (0131-536 3373, option 2 between 9am and 5 pm, Monday &#8211; Friday). VZV IgG testing is not performed during weekends, so that needs to be taken into consideration.<\/mark><\/strong><\/p>\n\n\n\n<p>For those needing advice out with these hours, please call the RIE switchboard and ask for the Virology consultant on call.<\/p>\n\n\n\n<p><strong>SR &amp; CM 4\/12\/2025<\/strong><\/p>\n\n\n\n<div class=\"wp-block-getwid-tabs\" data-active-tab=\"0\"><ul class=\"wp-block-getwid-tabs__nav-links\"><\/ul>\n<div class=\"wp-block-getwid-tabs__nav-link\"><span class=\"wp-block-getwid-tabs__title-wrapper\"><a href=\"#\"><span class=\"wp-block-getwid-tabs__title\">Resources and Links<\/span><\/a><\/span><\/div><div class=\"wp-block-getwid-tabs__tab-content-wrapper\"><div class=\"wp-block-getwid-tabs__tab-content\">\n<p>Please refer to the latest UK Health Security Agency version of the <a href=\"https:\/\/www.gov.uk\/government\/publications\/post-exposure-prophylaxis-for-chickenpox-and-shingles\/guidelines-on-post-exposure-prophylaxis-pep-for-varicella-or-shingles-january-2023\" target=\"_blank\" rel=\"noreferrer noopener\">post-exposure prophylaxis guidance for varicella or shingles<\/a>.<\/p>\n<\/div><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Please see full details at: post-exposure prophylaxis guidance for varicella or shingles. Chickenpox (varicella) infection in immunosuppressed individuals, susceptible pregnant individuals and neonates can result in severe and even life-threatening varicella disease. Post-exposure prophylaxis (PEP) is recommended to attenuate disease and reduce the risk of complications such as pneumonitis, rather than to prevent infection in<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":4043,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[867],"class_list":["post-13203","page","type-page","status-publish","hentry","category-https-apps-nhslothian-scot-refhelp-guidelines-infectiousdiseases-post-exposure-prophylaxis-for-chicken-pox-and-shingles-varicella-zoster"],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"heatherlevy","author_link":"https:\/\/apps.nhslothian.scot\/refhelp\/author\/heatherlevy\/"},"rttpg_comment":0,"rttpg_category":" <a href=\"https:\/\/apps.nhslothian.scot\/refhelp\/category\/infectiousdiseases\/https-apps-nhslothian-scot-refhelp-guidelines-infectiousdiseases-post-exposure-prophylaxis-for-chicken-pox-and-shingles-varicella-zoster\/\" rel=\"tag\">Post-exposure Prophylaxis for Chicken Pox and Shingles (Varicella Zoster)<\/a>","rttpg_excerpt":"Please see full details at: post-exposure prophylaxis guidance for varicella or shingles. Chickenpox (varicella) infection in immunosuppressed individuals, susceptible pregnant individuals and neonates can result in severe and even life-threatening varicella disease. Post-exposure prophylaxis (PEP) is recommended to attenuate disease and reduce the risk of complications such as pneumonitis, rather than to prevent infection in","_links":{"self":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/13203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/comments?post=13203"}],"version-history":[{"count":10,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/13203\/revisions"}],"predecessor-version":[{"id":25828,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/13203\/revisions\/25828"}],"up":[{"embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/4043"}],"wp:attachment":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/media?parent=13203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/categories?post=13203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}